Camlin Fine Sciences Limited (BOM:532834)

India flag India · Delayed Price · Currency is INR
165.45
-1.10 (-0.66%)
At close: Apr 21, 2025
48.76%
Market Cap 31.89B
Revenue (ttm) 16.54B
Net Income (ttm) -2.15B
Shares Out 187.92M
EPS (ttm) -12.82
PE Ratio n/a
Forward PE 29.39
Dividend n/a
Ex-Dividend Date n/a
Volume 105,706
Average Volume 99,283
Open 167.65
Previous Close 166.55
Day's Range 164.30 - 173.30
52-Week Range 80.00 - 180.95
Beta 0.46
RSI 57.74
Earnings Date May 19, 2025

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxi... [Read more]

Industry Chemicals and Allied Products
Founded 1931
Employees 624
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532834
Full Company Profile

Financial Performance

Financial Statements

News

Camlin Fine Sciences Q3 FY25 results: Revenue rises 8.7% YoY to Rs 435.5 crore, net loss at Rs 158.2 crore

The company attributed the net loss to several factors, including impairments on overseas subsidiaries, non-cash adjustments, and foreign exchange losses.

2 months ago - Business Upturn

Top stocks to buy today: Stock recommendations for February 7, 2025

Stock market recommendations: Bajaj Broking Research recommends buying Camlin Fine Sciences and Equinox India Developments for favorable stock positions. The Nifty is expected to sustain a positive bi...

2 months ago - The Times of India

Q1 2025 Camlin Fine Sciences Ltd Earnings Call Transcript

Q1 2025 Camlin Fine Sciences Ltd Earnings Call Transcript

9 months ago - GuruFocus